UK National Health Service Chickenpox Vaccine

The United Kingdom — National Health Service in the United Kingdom has launched a new childhood immunization program, incorporating a chickenpox (varicella) vaccine into the routine schedule. Starting January 2, 2026, a combined MMRV vaccine will be offered to children, replacing the existing MMR jab. This initiative follows a recommendation from the United Kingdom — Joint Committee on Vaccination and Immunisation and aims to protect young children from serious complications of chickenpox, which can lead to hospitalisation. Health Secretary Wes Streeting, National Medical Director for United Kingdom — National Health Service England Claire Fuller, and Deputy Director of Immunisation at the UK Health Security Agency Gayatri Amirthalingam have all highlighted the significant health and economic benefits of this rollout. The program is projected to save the United Kingdom £24 million annually in lost income and productivity and the United Kingdom — National Health Service £15 million per year in treatment costs. The vaccine schedule varies based on birth year, with a catch-up program planned for older children. The MMRV vaccine has been safely used for decades in countries like the United States, Canada, Australia, and Germany, demonstrating its effectiveness in reducing chickenpox cases and hospital admissions.